ASX:RMDHealth Care Equipment & ServicesHealth Care Equipment
RESMED CDI
$29.205
+$0.455 (+1.58%)
Day Range
$28.980 - $29.300
52 Week Range
$27.250 - $45.250
Volume
424.34K
Market Cap
$16.48B
Price Chart
Market Statistics
Open$29.110
Previous Close$28.750
Day High$29.300
Day Low$28.980
52 Week High$45.250
52 Week Low$27.250
Valuation
Market Cap16.48B
Shares Outstanding564.29M
Trading Activity
Volume424.34K
Value Traded12.40M
Bid$29.200 × 865
Ask$29.210 × 2
Technical Indicators
RSI (14)45.13
50-Day SMA$31.177
200-Day SMA$37.260
Latest News
ASX 200Biotechnology
ResMed delivers double-digit EPS growth on increasing demand for sleep apnoea devices
ResMed (ASX: RMD) has reported double-digit earnings per share (EPS) growth for the three months to March on the back of increasing market demand for its best-in-class sleep apnoea products and software solutions. The company’s revenue for the period increased by 8% to US$1.3 billion (up 9% on a constant currency basis), while income from […]
2 min read
ASX 200Technology
ResMed shares hit as Eli Lilly’s weight loss drug demonstrates sleep apnoea benefits
Medical device maker ResMed (ASX: RMD) saw its shares tumble more than 13% after pharmaceutical rival Eli Lilly announced that its weight-loss drug Zepbound (tirzepatide) could also help resolve sleep apnoea in some patients. California-based ResMed is a giant in the sleep apnoea space, manufacturing face masks, nasal devices and continuous positive airway pressure (PAP) […]
2 min read